Published November 2018 | Version v1
Journal article Metadata-only

C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy

Creators

  • 1. Department of Radiology, Massachusetts General Hospital, Boston (United States)
  • 2. Department of Radiation Oncology, Massachusetts General Hospital, Boston (United States)

Description

Response criteria of glioblastoma after chemoradiation do not account for metabolic changes that occur after treatment. The purpose of this study is to evaluate the utility of positron emission tomography (PET) imaging with C11 methionine (MET) (MET-PET) for detecting changes that occur after chemoradiation therapy and the value of molecular biomarkers for predicting the magnitude of metabolic response.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2018.06.011

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2018.06.011;
PII
S0360301618309647;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
102
Journal Issue
4
Journal Page Range
p. 1024-1028
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
54107094
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
BIOLOGICAL MARKERS; GLIOMAS; METHIONINE; POSITRON COMPUTED TOMOGRAPHY
Descriptors DEC
AMINO ACIDS; CARBOXYLIC ACIDS; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; LIPOTROPIC FACTORS; NEOPLASMS; NERVOUS SYSTEM DISEASES; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC SULFUR COMPOUNDS; TOMOGRAPHY

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.